
Peter G. Collin, MD
Advertisement
Collin is a second-year infectious diseases fellow at Beth Israel Deaconess Medical Center.
Articles by Peter G. Collin, MD


The significance of antiretroviral therapy (ART) has been a game changer for people living with HIV (PLWH). Still, there are some cardiovascular risks associated with different ART classes—particularly protease inhibitors (PIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), and integrase strand transfer inhibitors (INSTIs). Authors review a piece in the literature around this area of study.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Pritelivir Improves Outcomes in Immunocompromised Patients With Refractory Herpes Simplex Virus
2
Measles Update: February 6, 2026
3
PASTEUR Act Reintroduced in Congress
4
Antibiotics Deconstructed: IV Fosfomycin
5
